Your browser doesn't support javascript.
loading
Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasis.
Zachariae, Claus; Gordon, Kenneth; Kimball, Alexandra B; Lebwohl, Mark; Blauvelt, Andrew; Leonardi, Craig; Braun, Daniel; McKean-Matthews, Missy; Burge, Russel; Cameron, Gregory.
Afiliación
  • Zachariae C; University Hospital of Copenhagen Gentofte, Copenhagen, Denmark. Electronic address: claus.zachariae@regionh.dk.
  • Gordon K; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Kimball AB; Harvard Medical School, Boston, Massachusetts.
  • Lebwohl M; Mount Sinai Medical Center, New York, New York.
  • Blauvelt A; Oregon Medical Research Center, Portland, Oregon.
  • Leonardi C; Department of Dermatology, Saint Louis University School of Medicine, St. Louis, Missouri.
  • Braun D; Eli Lilly and Company, Indianapolis, Indiana.
  • McKean-Matthews M; Syneos Health, Ann Arbor, Michigan.
  • Burge R; Eli Lilly and Company, Indianapolis, Indiana.
  • Cameron G; Eli Lilly and Company, Indianapolis, Indiana.
J Am Acad Dermatol ; 79(2): 294-301.e6, 2018 Aug.
Article en En | MEDLINE | ID: mdl-29653208
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Interleucina-17 / Fármacos Dermatológicos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Interleucina-17 / Fármacos Dermatológicos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Año: 2018 Tipo del documento: Article